These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9520907)

  • 1. Growth hormone in postmenopausal women after long-term oral estrogen replacement therapy.
    Moe KE; Prinz PN; Larsen LH; Vitiello MV; Reed SO; Merriam GR
    J Gerontol A Biol Sci Med Sci; 1998 Mar; 53(2):B117-24. PubMed ID: 9520907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of estrogen and medroxyprogesterone on basal and stress-induced growth hormone release, IGF-1 levels, and cellular immunity in postmenopausal women.
    Malarkey WB; Burleson M; Cacioppo JT; Poehlmann K; Glaser R; Kiecolt-Glaser JK
    Endocrine; 1997 Oct; 7(2):227-33. PubMed ID: 9549049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aging and estradiol supplementation on GH axis dynamics in women.
    Lieman HJ; Adel TE; Forst C; von Hagen S; Santoro N
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3918-23. PubMed ID: 11502833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
    Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
    Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women.
    van Amelsvoort T; Murphy DG; Robertson D; Daly E; Whitehead M; Abel K
    Psychoneuroendocrinology; 2003 Jan; 28(1):101-12. PubMed ID: 12445839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    Bellantoni MF; Harman SM; Cho DE; Blackman MR
    J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
    Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
    Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
    Anderson SM; Shah N; Evans WS; Patrie JT; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum levels of growth hormone and insulin-like growth factor-I associated with simultaneous decrease of circulating insulin in postmenopausal women receiving hormone replacement therapy.
    Fonseca E; Ochoa R; Galván R; Hernández M; Mercado M; Zárate A
    Menopause; 1999; 6(1):56-60. PubMed ID: 10100181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
    Veldhuis JD; Anderson SM; Kok P; Iranmanesh A; Frystyk J; Ørskov H; Keenan DM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1312-8. PubMed ID: 15001627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
    Friend KE; Hartman ML; Pezzoli SS; Clasey JL; Thorner MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2250-6. PubMed ID: 8964860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women.
    Gibney J; Johannsson G; Leung KC; Ho KK
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3897-903. PubMed ID: 15855258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study.
    Goodman-Gruen D; Barrett-Connor E
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4268-71. PubMed ID: 8954026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.